天津市河西区某社区老年高血压现状的调查分析
|
摘要
目的：通过对天津市河西区某社区老年高血压流行病学及其相关危险因素的调查,了解本社区老年高血压的流行特点、分布特征、影响因素、高血压患者血脂情况及其服药依从性等,为进一步制定社区人群高血压的防治的相关政策、采取针对性的控制措施提供依据。
方法：选取天津市河西区某社区老年人6202人,进行高血压的流行病学调查。用统一的问卷并采用直接询问法进行,详细记录患者人口学特征、高血压的既往史及家族史等。按随机抽样的原则从中抽取部分样本进行血脂、血糖检验。分别按性别、年龄、BMI、WC、WHR、WHtR、FBG和高血压分级等分组进行分析、比较。
结果：1.天津市河西区某社区老年人的SBP和DBP平均水平分别为137.27±20.71mmHg和78.42±9.12mmHg。男、女SBP和DBP平均水平都随着年龄增高而升高。超重、肥胖、腹部肥胖和IFG人群的SBP和DBP平均水平均较高,SBP和DBP平均水平随着BMI、WC、WHR、WHtR和FBG的升高都呈现逐渐上升的趋势。2.6202名调查对象中,高血压患者为2716人,高血压粗患病率和标化患病率分别为43.8%和41.8%。男性分别为40.6%和38.7%,女性分别为46.4%和44.3%,女性患病率高于男性,差异有统计学意义(P=0.000)；男女高血压患病率随年龄的升高呈上升趋势(趋势χ2male=13.537,P<0.01;趋势χ2female=26.148,P=0.000)。小学及其以下、初中、高中或中专、大专及其以上等文化程度的患病率分别为47.0%、44.7%、41.2%、40.2%,高血压患病率随文化程度的升高呈下降趋势(趋势χ2=11.788,P=0.000)。工人、科医教商、离退、家务高血压患病率分别为26.2%、25.2%、44.9%、42.3%,差异有统计学意义(P=0.000)。离婚丧偶人群、已婚人群高血压患病率分别为48.2%、42.4%,差异有统计学意义(P=0.000)。3.体重不足组、正常组、超重组、肥胖组的高血压患病率分别为22.1%、36.4%、46.2%、63.8%,差异有统计学意义(P=0.000)。高血压患病率随BMI的升高呈上升趋势(趋势χ2=237.957,P=0.000)。腹型肥胖组患病率较正常组高,差异有统计学意义(P=0.000)。4.高血压1、2、3级患病率分别为22.3%、12.6%、8.8%,差异有统计学意义(P=0.000)。构成比分别为51.0%、28.8%、20.2%,差异无统计学意义(P=0.287)。ISH患病率26.7%,非ISH为17.1%,差异有统计学意义(P=0.000)。ISH、IDH、SDH构成比分别为61.0%、2.0%、36.9%,差异有统计学意义(P=0.000)。5.年龄、文化程度、职业、家族史、BMI、WC、TG和FBG可能是影响高血压患病的独立因素。6.患者知晓率、治疗率、控制率、治疗者控制率分别为68.2%、64.1%、18.5%、28.9%,其中男性为66.7%、61.6%、20.0%、32.5%,女性为69.3%、65.8%、17.5%、26.5%,男女治疗率和治疗者的控制率,差异有统计学意义(χ2=5.507,P=0.025；χ2=7.233,P=0.007)。7.高血压患者中,超重率、肥胖率、TC异常率、TG异常率、HDL-c异常率、LDL-c异常率及总血脂异常率男女之间差异均有统计学意义(P<0.01)；除了超重和HDL-c异常率男性高于女性外,余女性均高于男性。8.在高血压分级中,TC、TG差异有统计学意义(P<0.05)。在高血压类型中,TC、TG、HDL-c、LDL-c、FBG差异均无统计学意义(P≥0.05)。9.在不同BMI分组中,TG、HDL-c、LDL-c、FBG差异有统计学意义(P<0.01),TG、LDL-c、FBG水平随着BMI的增大而升高，HDL-c随着BMI的增大而降低。腹型肥胖者TC、TG、LDL-c、FBG的水平较正常组高,HDL-c水平较正常组低,部分差异有统计学意义(P<0.01)。10.女性血脂水平及异常率均高于男性,部分差异有显著性(P<0.05)。11.高血压患者CPAT佳者占67.1%；不佳者占32.9%。患者是否规律自测血压、服药种数和服药次数可能是影响CPAT的独立因素。高血压患者使用一种降压药的占71.3%,其中用前三位的是中药、CCB、复方制剂,分别占25.6%、24.8%、21.3%,服药依从性较佳的前三类药为CCB、中药、复方制剂,分别占28.1%、22.7%、21.8%(P=0.688)；联合用药占21.5%,其中符合2005年高血压指南的占26.9%。
结论：天津市河西区某社区老年居民SBP和DBP平均水平均高于全国水平。老年高血压粗患病率和标化患病率较高,女性患病率高于男性,男女患病率最高组均出现在III组。在高血压分级中,1级高血压所占比例最高；在高血压类型中,ISH所占比例最高。年龄、文化程度、职业、家族史、BMI、WC、TG和FBG可能是影响高血压患病的独立因素。高血压知晓率、治疗率、控制率和高血压治疗者控制率与美国等发达国家相比仍较低。高血压患者代谢性疾病患病率均高于国内水平。社区CPAT较差,应加强社区干预,普及并落实高血压指南,强化高血压健康教育,选择最佳治疗方案,大力推广家庭自测血压,以提高高血压患者药物治疗依从性。
Objective:To analyze the situation of epidemiological characteristics, distribution characteristics, risk factors,serum lipid and drug compliance of elderly hypertensive patients through investigating epidemiology and risk factors of elderly hypertensive patients in Hexi District of Tianjin. In order to further develop our public health and disease control policy.
Methods:Study objects with 6702 elderly persons in Hexi District of Tianjin. demographic characteristics, hypertension history and family history were selected by questionnaire investigation and face-to-face interview. Serum lipid and blood sugar were detected in some of sample. The data were divided into different groups according age, sex, BMI, WC, WHR, WHtR, FBG, class of hypertension to analyze and compare respectively.
Results:1.The mean of SBP and DBP were 137.27±20.71 mmHg and 78.42±9.12 mmHg respectively in the target population. Both means of SBP and DBP increased progressively with age for men and women. The means of SBP and DBP were higher for the population of over weight, obesity, abdomen obesity and IFG., both means of SBP and DBP increased progressively with the growth of BMI, WC, WHR, WHtR and FBG..2. Of 6202 subjects in this study,2716 were diagnosed as the patients of hypertension. The crude prevalence and the standardized prevalence of hypertension were 43.8% and 41.8% respectively. The male prevalence of that were 40.6% and 38.7%, and the female prevalence of that were 46.4% and 44.3%, the female prevalence of that was higher than the male (P=0.000). The male prevalence of hypertension increased with age increasing, and so did the female (trend chi-square testχ2male=13.537, P<0.01; trend chi-square testχ2female=26.148,P=0.000).The prevalence of hypertension were 47.0%,44.7%,41.2% and 40.2% for people with primary school education and below, junior high school education, senior high school and junior college education, college education and above. The prevalence of hypertension decreased with education increasing (P=0.000).For workers, people of the business, teacher, scientists and doctors, the retired and the unemployed, the prevalence of hypertension is respectively 26.2%,25.2%,44.9% and 42.3%,there was significant difference between occupations (P=0.000). For the divorced and bereaved,the normal married, the prevalence of hypertension is respectively 48.2% and 42.4%,there was significant difference between different marry condition (P=0.000).3.The prevalence of hypertension of underweight, normal weight group, over weight and obesity were respectively 22.1%,36.4%,46.2% and 63.8%, obesity is the highest, underweight is the lowest (P=0.000).The prevalence of hypertension increased with BMI increasing (trend chi-square testχ2=237.957, P=0.000). The prevalence of hypertension of abdominal obesity group was higher than normal group (P=0.000).4.Among the hypertensive patients, the prevalence of hypertension of grade 1,2,3 were respectively 22.3%,12.6% and 8.8%, grade 1 hypertension patients is the highest, grade 2 the second,and grade 3 the lowest (P=0.000), the proportion of those is respectively 51.0%,28.8% and 20.2%,there were no significant difference (P=0.287). The prevalence of ISH is 26.7%, the other is 17.1%, the proportion of ISH, IDH and SDH were respectively 61.0%,2.0% and 36.9%, ISH was the highest, SDH the second, and IDH the lowest (P=0.000).5. Age, education, occupation, hypertension family history, BMI, WC, TG and FBG were the independent and significant factors influencing hypertension. 6. The hypertension awareness, treatment, control and control rate of the treated were respectively 68.2%, 64.1%,18.5%and 28.9%, the male of that were respectively 66.7%,61.6%,20.0 % and 32.5%, the female of that were respectively 69.3%,65.8%,17.5% and 26.5 %, the female of treatment rate was higher than the male (χ2=5.507, P=0.025), the male of the treated control rate was higher than the female (χ2=7.233,.P=0.007).7. Among the hypertension patients, over weight, obesity, the abnormal rate of TG, TC, HDL-c, LDL-c and the total abnormal rate of serum lipid were significant difference between the male and the female (P<0.01),the male of over weight and the abnormal rate of HDL-c were higher than the female, the female of the other were higher than the male.8.TC and TG were significant difference between different class of hypertension (P<0.05).TC, TG, HDL-c, LDL-c and FBG were no significant difference in different type of hypertension (P≥0.05).9. TG, HDL-c,LDL-c and FBG were significant difference between different class of BMI (P<0.01).The level of TG, LDL-c and FBG increased with BMI increasing, the level of HDL-c decreased with BMI increasing. The level of TC, TG, LDL-c and FBG of abdominal obesity group were higher than normal group, the level of HDL-c decreased with BMI increasing. The level of HDL-c of abdominal obesity group was lower than normal group, part of them were significant difference (P<0.01).10. The level and abnormal rate of serum lipid of the female were higher than the male, part of them were significant difference between sex (P<0.05).11. The compliance rate was 67.1% and non-compliance was 32.9%. Regularity of home blood pressure monitoring, types and frequency of medication were the independent and significant factors influencing medical compliance. The patients use one kind of antihypertensive drug was 71.3%, the first three were the traditional Chinese medicine, CCB and compound preparation. The proportion of them were respectively 25.6%,24.8% and 21.3%.Better drug compliance of the first three kinds of drugs were CCB,the traditional Chinese medicine and compound preparation. The proportion of them were respectively 28.1%,22.7% and 21.8%.The proportion of drug combination was 21.5%, the proportion of consistent with prevention and treatment of Chinese hypertension guidelines was 26.9%.
Conclusion:The mean of SBP and DBP of elderly hypertensive patients in Hexi District of Tianjin were higher than National level.The crude prevalence and the standardized prevalence of hypertension were higher, the female prevalence of that was higher than the male,the highest was group of 70～79 years.The prevalence of hypertension of grade 1 was highest among different class of hypertension, the prevalence of ISH was highest among different kind of hypertension. Age, education, occupation, hypertension family history, BMI, WC, TG and FBG were the independent and significant factors influencing hypertension. The hypertension awareness, treatment, control and therapist control rate were lower than United States and other developed countries.The prevalence of metabolic diseases among hypertension patients was higher than national level. The situation of CPAT was bad, to implement of hypertension guidelines, promote health education, choose the best treatment options, and call to action on use and reimbursement for home blood pressure monitoring could improve Compliance of Patient with Anti-hypertension Therapy.
方法：选取天津市河西区某社区老年人6202人,进行高血压的流行病学调查。用统一的问卷并采用直接询问法进行,详细记录患者人口学特征、高血压的既往史及家族史等。按随机抽样的原则从中抽取部分样本进行血脂、血糖检验。分别按性别、年龄、BMI、WC、WHR、WHtR、FBG和高血压分级等分组进行分析、比较。
结果：1.天津市河西区某社区老年人的SBP和DBP平均水平分别为137.27±20.71mmHg和78.42±9.12mmHg。男、女SBP和DBP平均水平都随着年龄增高而升高。超重、肥胖、腹部肥胖和IFG人群的SBP和DBP平均水平均较高,SBP和DBP平均水平随着BMI、WC、WHR、WHtR和FBG的升高都呈现逐渐上升的趋势。2.6202名调查对象中,高血压患者为2716人,高血压粗患病率和标化患病率分别为43.8%和41.8%。男性分别为40.6%和38.7%,女性分别为46.4%和44.3%,女性患病率高于男性,差异有统计学意义(P=0.000)；男女高血压患病率随年龄的升高呈上升趋势(趋势χ2male=13.537,P<0.01;趋势χ2female=26.148,P=0.000)。小学及其以下、初中、高中或中专、大专及其以上等文化程度的患病率分别为47.0%、44.7%、41.2%、40.2%,高血压患病率随文化程度的升高呈下降趋势(趋势χ2=11.788,P=0.000)。工人、科医教商、离退、家务高血压患病率分别为26.2%、25.2%、44.9%、42.3%,差异有统计学意义(P=0.000)。离婚丧偶人群、已婚人群高血压患病率分别为48.2%、42.4%,差异有统计学意义(P=0.000)。3.体重不足组、正常组、超重组、肥胖组的高血压患病率分别为22.1%、36.4%、46.2%、63.8%,差异有统计学意义(P=0.000)。高血压患病率随BMI的升高呈上升趋势(趋势χ2=237.957,P=0.000)。腹型肥胖组患病率较正常组高,差异有统计学意义(P=0.000)。4.高血压1、2、3级患病率分别为22.3%、12.6%、8.8%,差异有统计学意义(P=0.000)。构成比分别为51.0%、28.8%、20.2%,差异无统计学意义(P=0.287)。ISH患病率26.7%,非ISH为17.1%,差异有统计学意义(P=0.000)。ISH、IDH、SDH构成比分别为61.0%、2.0%、36.9%,差异有统计学意义(P=0.000)。5.年龄、文化程度、职业、家族史、BMI、WC、TG和FBG可能是影响高血压患病的独立因素。6.患者知晓率、治疗率、控制率、治疗者控制率分别为68.2%、64.1%、18.5%、28.9%,其中男性为66.7%、61.6%、20.0%、32.5%,女性为69.3%、65.8%、17.5%、26.5%,男女治疗率和治疗者的控制率,差异有统计学意义(χ2=5.507,P=0.025；χ2=7.233,P=0.007)。7.高血压患者中,超重率、肥胖率、TC异常率、TG异常率、HDL-c异常率、LDL-c异常率及总血脂异常率男女之间差异均有统计学意义(P<0.01)；除了超重和HDL-c异常率男性高于女性外,余女性均高于男性。8.在高血压分级中,TC、TG差异有统计学意义(P<0.05)。在高血压类型中,TC、TG、HDL-c、LDL-c、FBG差异均无统计学意义(P≥0.05)。9.在不同BMI分组中,TG、HDL-c、LDL-c、FBG差异有统计学意义(P<0.01),TG、LDL-c、FBG水平随着BMI的增大而升高，HDL-c随着BMI的增大而降低。腹型肥胖者TC、TG、LDL-c、FBG的水平较正常组高,HDL-c水平较正常组低,部分差异有统计学意义(P<0.01)。10.女性血脂水平及异常率均高于男性,部分差异有显著性(P<0.05)。11.高血压患者CPAT佳者占67.1%；不佳者占32.9%。患者是否规律自测血压、服药种数和服药次数可能是影响CPAT的独立因素。高血压患者使用一种降压药的占71.3%,其中用前三位的是中药、CCB、复方制剂,分别占25.6%、24.8%、21.3%,服药依从性较佳的前三类药为CCB、中药、复方制剂,分别占28.1%、22.7%、21.8%(P=0.688)；联合用药占21.5%,其中符合2005年高血压指南的占26.9%。
结论：天津市河西区某社区老年居民SBP和DBP平均水平均高于全国水平。老年高血压粗患病率和标化患病率较高,女性患病率高于男性,男女患病率最高组均出现在III组。在高血压分级中,1级高血压所占比例最高；在高血压类型中,ISH所占比例最高。年龄、文化程度、职业、家族史、BMI、WC、TG和FBG可能是影响高血压患病的独立因素。高血压知晓率、治疗率、控制率和高血压治疗者控制率与美国等发达国家相比仍较低。高血压患者代谢性疾病患病率均高于国内水平。社区CPAT较差,应加强社区干预,普及并落实高血压指南,强化高血压健康教育,选择最佳治疗方案,大力推广家庭自测血压,以提高高血压患者药物治疗依从性。
Objective:To analyze the situation of epidemiological characteristics, distribution characteristics, risk factors,serum lipid and drug compliance of elderly hypertensive patients through investigating epidemiology and risk factors of elderly hypertensive patients in Hexi District of Tianjin. In order to further develop our public health and disease control policy.
Methods:Study objects with 6702 elderly persons in Hexi District of Tianjin. demographic characteristics, hypertension history and family history were selected by questionnaire investigation and face-to-face interview. Serum lipid and blood sugar were detected in some of sample. The data were divided into different groups according age, sex, BMI, WC, WHR, WHtR, FBG, class of hypertension to analyze and compare respectively.
Results:1.The mean of SBP and DBP were 137.27±20.71 mmHg and 78.42±9.12 mmHg respectively in the target population. Both means of SBP and DBP increased progressively with age for men and women. The means of SBP and DBP were higher for the population of over weight, obesity, abdomen obesity and IFG., both means of SBP and DBP increased progressively with the growth of BMI, WC, WHR, WHtR and FBG..2. Of 6202 subjects in this study,2716 were diagnosed as the patients of hypertension. The crude prevalence and the standardized prevalence of hypertension were 43.8% and 41.8% respectively. The male prevalence of that were 40.6% and 38.7%, and the female prevalence of that were 46.4% and 44.3%, the female prevalence of that was higher than the male (P=0.000). The male prevalence of hypertension increased with age increasing, and so did the female (trend chi-square testχ2male=13.537, P<0.01; trend chi-square testχ2female=26.148,P=0.000).The prevalence of hypertension were 47.0%,44.7%,41.2% and 40.2% for people with primary school education and below, junior high school education, senior high school and junior college education, college education and above. The prevalence of hypertension decreased with education increasing (P=0.000).For workers, people of the business, teacher, scientists and doctors, the retired and the unemployed, the prevalence of hypertension is respectively 26.2%,25.2%,44.9% and 42.3%,there was significant difference between occupations (P=0.000). For the divorced and bereaved,the normal married, the prevalence of hypertension is respectively 48.2% and 42.4%,there was significant difference between different marry condition (P=0.000).3.The prevalence of hypertension of underweight, normal weight group, over weight and obesity were respectively 22.1%,36.4%,46.2% and 63.8%, obesity is the highest, underweight is the lowest (P=0.000).The prevalence of hypertension increased with BMI increasing (trend chi-square testχ2=237.957, P=0.000). The prevalence of hypertension of abdominal obesity group was higher than normal group (P=0.000).4.Among the hypertensive patients, the prevalence of hypertension of grade 1,2,3 were respectively 22.3%,12.6% and 8.8%, grade 1 hypertension patients is the highest, grade 2 the second,and grade 3 the lowest (P=0.000), the proportion of those is respectively 51.0%,28.8% and 20.2%,there were no significant difference (P=0.287). The prevalence of ISH is 26.7%, the other is 17.1%, the proportion of ISH, IDH and SDH were respectively 61.0%,2.0% and 36.9%, ISH was the highest, SDH the second, and IDH the lowest (P=0.000).5. Age, education, occupation, hypertension family history, BMI, WC, TG and FBG were the independent and significant factors influencing hypertension. 6. The hypertension awareness, treatment, control and control rate of the treated were respectively 68.2%, 64.1%,18.5%and 28.9%, the male of that were respectively 66.7%,61.6%,20.0 % and 32.5%, the female of that were respectively 69.3%,65.8%,17.5% and 26.5 %, the female of treatment rate was higher than the male (χ2=5.507, P=0.025), the male of the treated control rate was higher than the female (χ2=7.233,.P=0.007).7. Among the hypertension patients, over weight, obesity, the abnormal rate of TG, TC, HDL-c, LDL-c and the total abnormal rate of serum lipid were significant difference between the male and the female (P<0.01),the male of over weight and the abnormal rate of HDL-c were higher than the female, the female of the other were higher than the male.8.TC and TG were significant difference between different class of hypertension (P<0.05).TC, TG, HDL-c, LDL-c and FBG were no significant difference in different type of hypertension (P≥0.05).9. TG, HDL-c,LDL-c and FBG were significant difference between different class of BMI (P<0.01).The level of TG, LDL-c and FBG increased with BMI increasing, the level of HDL-c decreased with BMI increasing. The level of TC, TG, LDL-c and FBG of abdominal obesity group were higher than normal group, the level of HDL-c decreased with BMI increasing. The level of HDL-c of abdominal obesity group was lower than normal group, part of them were significant difference (P<0.01).10. The level and abnormal rate of serum lipid of the female were higher than the male, part of them were significant difference between sex (P<0.05).11. The compliance rate was 67.1% and non-compliance was 32.9%. Regularity of home blood pressure monitoring, types and frequency of medication were the independent and significant factors influencing medical compliance. The patients use one kind of antihypertensive drug was 71.3%, the first three were the traditional Chinese medicine, CCB and compound preparation. The proportion of them were respectively 25.6%,24.8% and 21.3%.Better drug compliance of the first three kinds of drugs were CCB,the traditional Chinese medicine and compound preparation. The proportion of them were respectively 28.1%,22.7% and 21.8%.The proportion of drug combination was 21.5%, the proportion of consistent with prevention and treatment of Chinese hypertension guidelines was 26.9%.
Conclusion:The mean of SBP and DBP of elderly hypertensive patients in Hexi District of Tianjin were higher than National level.The crude prevalence and the standardized prevalence of hypertension were higher, the female prevalence of that was higher than the male,the highest was group of 70～79 years.The prevalence of hypertension of grade 1 was highest among different class of hypertension, the prevalence of ISH was highest among different kind of hypertension. Age, education, occupation, hypertension family history, BMI, WC, TG and FBG were the independent and significant factors influencing hypertension. The hypertension awareness, treatment, control and therapist control rate were lower than United States and other developed countries.The prevalence of metabolic diseases among hypertension patients was higher than national level. The situation of CPAT was bad, to implement of hypertension guidelines, promote health education, choose the best treatment options, and call to action on use and reimbursement for home blood pressure monitoring could improve Compliance of Patient with Anti-hypertension Therapy.
引文
[1]He J, Gu D, Wu X, et al. Major causes of death among men and women in China [J]. N Engl J Med,2005,353(11):1124-34.
[2]Guzik HJ, Ooi WL. Hypertension:cardiovascular implications in a cohort of old old [J]. J Am Geriatr Soc.1992,40(4):348-53.
[3]全国血压抽样调查协作组,中国高血压的患病率、知晓率及治疗和控制状况：1991年抽样调查结果.高血压杂志.1995,3：14-19.
[4]李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查[J].中华流行病学.2005,26：481-482.
[5]顾东风,JiangHe,吴锡桂,等.中国成年人高血压患病率、知晓率、治疗和控制状况[J].中华预防医学杂志,2003,37(2)：84-85.
[6]徐定修,杨鹏麟.温州市区老年高血压患病率,治疗率及控制情况的调查[J].实用老年医学,1999,13(2)：94-95.
[7]陈春明,孔灵芝.中国成人超重与肥胖症预防控制指南[M].北京：人民卫生出版社,2006：3.
[8]《中国高血压防治指南》2007.
[9]中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值：适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(01)：5-10.
[10]郭子宏,刘锦桃,胡世云,等.云南省长寿地区老年人血压水平调查[J].中华老年医学杂志,2004,23(6)：422-425.
[11]全国血压抽样调查协作组.中国人群体重指数及其与血压关系现况抽样调查研究[J].高血压杂志,1995,3(51)：31-35.
[12]李欣,李绥晶,金旭伟,等.辽宁地区居民体重指数、腰围与血压关系的研究[J].中国预防医学杂志,2007,8(3)：161-163.
[13]王薇,赵冬,刘静,等.中国35-64岁人群血压水平与10年心血管病发病危险的前瞻性究[J].中华内科杂志,2004,43(10)：730-734.
[14]Liu LS, Wang JG, Gong LS, et al. Comparison of active treatment and placebo for older Patients with isolated systolic hypertension [J]. Hypertens.1998,16: 1823-1829.
[15]Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduetion on blood Pressure:a meta-analysis of randomized controlled trials [J]. HyPertension,2003, 42(5):878-884.
[16]JuliusS, Valentini M, Palatini P, et al. Overweight and HyPertension a 2-way street? [J]. HyPertension,2000,35(3):807-813.
[17]赵连成,周北凡,武阳丰,等.体重指数与死亡的前瞻性研究[J].中华流行病学志,2002,23(1)：24-27.
[18]de Jong PE, Vethave JC, Pinto-Sietsma SJ, et al. Obesity and target organ damage:the kidney [J].2002,26(54):21-24.
[19]Hurbert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease:a 26 year follow-up of Participants in Framingham Heart Study [J]. Circulation,1983,67(5):968-977.
[20]方向华,汤哲,平光字,等.北京社区老年人群高血压防治现况的综合评价[J].中华老年医学杂志,2004,23：659-662.
[21]Patricia M Kearney, Megan Whelton, Kristi Reynolds, et al. global burden Of hypertension:analysis of worldwide data [J]. Lancet 2005,365(9455):217-223.
[22]段秀芳,吴锡桂,顾东风,等.中国人群血压分类与高血压患病率研究-1991年血压抽样调查资料的进一步分析[J].高血压杂志,2002,10(3)：271-273.
[23]崔军,张涛,张莉娜,等.宁波市35-74岁城市居民高血压患病情况调查分析[J].疾病监测,2005,20(1)：40-43.
[24]李剑森,马文军,许燕君,等.广东省居民单纯收缩期高血压流行病学特征分析[J].华南预防医学,2003,29(6)：34-36.
[25]Primatesta P, Poulter NR. Hypertension management and control among English adults aged 65 years and older in 2000 and 2001 [J]. J Hypertens,2004,22: 1093-1098.
[26]Franklin SS, JacobsMJ, WongND, et al. Predominance of isolated systolic hypertensives. Analysis based on National Health and Nutrition Examination Survey(NHANES)Ⅲ[J]. Hypertension,2001,37:869-874.
[27]O.James Ekundayo, Richard M.Allman, Paul W.Sanders, et al. Isolated Systolic HyPertension and Incident Heart Failure in older Adults:A ProPensity-Matched Study [J]. HyPertension,2009,53(3):458-465.
[28]Kannel WB. Elevated systolic blood Pressure as a cardiovascular risk factor[J]. Am J Cardio,2000,85(2):251-255.
[29]商青,路方红,孟庆杰,等.山东章丘农民高血压患病率及其危险因素调查[J].中国慢性病预防与控制,2005,13(1)：31-32.
[30]Oliveria SA, Lauerta P, McCarthy BD, et al. physician-related barriers to the effective management of uncontrolled hypertension [J]. Arch Intern Med,2002, 162(4):413-420.
[31]陶寿淇,吴锡桂,周北凡,等.中国人群心血管危险因素作用特点的前瞻性研究[J].中华流行病学杂志,2005,26(1)：58-61.
[32]Stevens VJ, Corigan SA, Obarzanek E, et al. Weight loss intervention in phase I of the Trials of Hypertension Prevention.The TOHP Collaborative Researeh Group. Arch lntem Med.1993,153(7):849-858.
[33]Mulrow CD, Chiquette E, Angel L, et al. WITHDRAWN:Dieting to reduce body weight for controlling hypertension in adults [J]. Cochrane Database Syst Rev. 2008,8 (4):484.
[34]焦淑芳.北京市居民高血压患病及流行趋势分析[J].中国公共卫生,2005,21(12)：1491-1492.
[35]王丽娜,曹丽,张敬一,等.河北省成年居民高血压患病状况及相关因素分析[J].中国慢性病预防与控制,2008,16(2)：125-129.
[36]朱永锋,张娟,邓军,等.县级城乡高血压病防治的流行病学研究[J].大连医科大学学报,2008,30(1)：36-37.
[37]毛浩丹,吴建方,周义红,等.常州市农村地区人群高血压流行病学调查[J].疾病控制杂志,2005,9(5)：406-408.
[38]刘伟佳,陈维清,罗不凡,等.广州市15岁及以上居民高血压流行特征及患病现状[J].中国慢性病预防与控制,2007,15(2)：110-112.
[39]陈捷,赵秀丽,武峰,等.我国14省市中老年人肥胖超重流行现状及其与高血压患病率的关系[J].中华医学杂志,2005,85(40)：2830-2834.
[40]赵连成,武阳丰,周北凡,等.不同体重指数和腰围人群的高血压均值及高血压患病率调查[J].中华流行病学杂志,2003,24(6)：471-475.
[41]傅世英,曹雅,李耀平,等.黑龙江省高血压病流行病学的研究[J].ChioMed J,2002,115(4):498-501.
[42]马文军,林锦炎,陈泽池,等.广东省居民膳食营养与健康状况研究[M].广东人民出版社,2004.
[43]刘蓬勃,王学良,徐慧文,等.原发性高血压遗传流行病学研究.西安医科大 学学报,1996,17(1)：102.
[44]刘蓬勃,王学良,徐慧文,等.遗传因素与原发性高血压.中国公共卫生学报,1995,14(6)：352.
[45]Scott M, Bryan B, Janres I, et al. Definition of metabolic syndrome:Report of The National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues related to Definition. Circulation,2004,109(3): 433-438.
[46]Wilkinson IB, Prasad K, Hall IR, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol, 2002,39(6):1005-1011.
[47]Morisawa T, Kitano M. Influence of angiotensin II type 1 receptor Polymorphism on hyPertension in Patients with hypercholesterolemia. Clin Chim Acta,2001, 304:91.
[48]Ferrier KE, Muhlmarm MH, Baguet JP, et al. Intensive cholesterol reduction lowers blood pressure and large artery stifness in isolated systolic hypertension[J]. J Am Coll Cardiol,2002,39(6):1020-1025.
[49]Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States,1988-2000. JAMA,2003,290:199-206.
[50]Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment and control of hypertension among United States adults 1999-2004. Hypertension, 2007,49:69-75.
[51]张普洪,焦淑芳,周滢,等.北京市2005年18岁及以上居民主要慢性病的流行特征和防治水平调查[J].中华流行病学杂志,2007,28(7)：625-628.
[52]张心刚,孙兆青,叶爱群,等.辽宁省阜新农村地区高血压人群代谢异常研究[J].中华心血管病杂志,2007,35(7)：658-660.
[53]陈秋雯,周建新,赵炜磊,等.上海城乡结合部60岁以上居民的高血压血脂异常高血糖现况调查(附11220例报告)[J].临床心血管病杂志,2009,25(2)：125-128.
[54]Loyd-Jones DM, Evans JC, Larson MG, et al. Cross-classification of JNC VI blood pressure stages and risk group in the Framingham Heart study[J]. Arch Intern Med,1999,159(18):2206-2212.
[55]Wong ND, Pio JR, Franklin SS, et al. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome [J]. Am J cardiol,2003,91(12):1421-1426.
[56]方顺源,施世锋,刘庆敏,等.杭州市城乡居民超重及肥胖与相关疾病关系[J].中国公共卫生,2006,22(7)：852-855.
[57]张龙江.肥胖与胰岛素抵抗[J].实用儿科临床杂志,2009,24(20)：1548-1551.
[58]祁双宝,成守金,许风清,等.中老年高级知识分子1060人体脂分布类型与心血管病危险因素水平及聚集程度的关系[J].中国临床康复,2006,10(36)：7-10.
[59]Coambs R.B, Jensen P, Her MH, et al. Review of the scientific literature on the prevalence consequences and health costs of noncompliance & inappropriate use on prescription medication in Canada [M]. Health promotion research, university of Toronto Press,1995,100.
[60]Cuspidi C, Meani S, Lonati L, et al. Prevalence of home blood pressure measurement among selected hypertensive patients:results of a multicenter survey from six hospital outpatient hypertension clinics in Italy[J]. Blood Press, 2005,14(4):251-256.
[61]范维虎,谢绿洲,董乃琳,等.上海区居民高血压药物治疗概况的横断面调查[J].中国慢性病预防与控制,1994,2(5)：201-202.
[62]Aram V. Chobanian, George L. Bakris, Henry R. Black, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure[J]. Hypertension,2003,42:1206-1252.
[63]李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查[J].中华流行病学,2005,26：481-482.
[64]Eugenia Ch. Yiannakopoulou, John S. Papadopulos, Dennis V. Cokkinos, et al. Adherence to antihypertensive treatment:a critical factor for blood pressure control [J]. European Journal of Cardiovascular Prevention and Rehabilitation, 2005,12:243-249.
[65]Mark A. Munger, Benjamin W. Van Tassell, Joanne LaFleur, et al. Medication Nonadherence:An Unrecognized Cardiovascular Risk Factor[J]. MedGenMed,2007,9(3):58.
[66]陈首英,尹博英,李贞洁,等.影响高血压患者服药依从性因素调查[J].高血压杂志,2003,11(5)：486-488.
[67]于黎,朱大乔.原发性高血压患者药物治疗依从性影响因素的分析[J].解放军护理杂志,2004,21(12)：33-35.
[68]George J. Fodor, Marian Kotrec, Kinga Bacskai, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study [J]. Journal of Hypertension,2005,23:1261-1266.
[69]朱大乔,毛红娟,何丹丹,等.高血压患者自我监测血压对药物治疗依从性的影响[J].中华护理杂志,2004,39(8)：581-583.
[70]姚远,袁洪.降压达标的意义[J].医学综述,2007,13(11)：870.
[71]范维琥,蔡逎绳.高血压[M].见：陈灏珠.实用内科学12版.北京：人民卫生出版社,2005：1525-1544.
[72]张利.1406例高血压合并症分析及社区综合防治的意义[J].中国初级卫生保健,2005,19(8)：51-52.
[73]Xiang Gu, Chunzhi Shi, Yibai Feng, et al. Health education improves effectively therapy of inpatients with Hypertension [J]. Journal of Nanjing Medical University.2006,20(3):129-132.
[74]Richard S Cooper.Using public health indicators to measure the success of hypertension control [J]. Hypertension,2007,49:773-774.
[75]Stergiou GS, Kalogeropoulos PG, Baibas NM, et al. Prognostic value of home blood pressure measurement [J]. Blood Pressure Monitoring,2007,12 (6):391-392.
[76]谢伟林.影响高血压病老年患者治疗依从性的相关因素分析及对策[J].河北医学,2004,10(4)：353-355.
[77]刘建一,李杏桃,张鸿修,等.阶梯剂量联合用药适宜技术在人群高血压病防治中的应用[J].河北医药,2008,30(2)：238-239.
[78]刘建一.NAH治疗方案及微机软件系统在人群高血压病防治中的应用[J].中国慢性病预防与控制,1994,2(6)：272-273.
[79]Ira B.Wilson, Cathy Schoen, Patricia Neuman, et al. Physician-patient communication about prescription medication nonadherence:a 50-state study of America's seniors [J]. J Gen Intern Med,2007,22(1):6-12.
[80]Antoinette Schoenthaler, William F.Chaplin, John P. Allegrante, et al. Provider communication effects medication adherence in hypertensive African Americans[J]. Patient Education and Counseling,2009,75:185-191.
[81]Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence [J]. J Clin Hypertens (Greenwich), 2006,8:174-180.
[82]George S. Stergiou, Petros G. Prognostic value of home blood pressure measurement [J]. Blood Pressure Monitoring,2007,12(6):391-392.
[83]Margaret Scisney-Matlocka, Amy Grandb, Susan P. Steigerwalt, et al. Reliability and reproducibility of clinic and home blood pressure measurements in hypertensive women according to age and ethnicity[J]. Blood Pressure Monitoring,2009,14 (2):49-56.
[84]Brent M. Egan, Daniel T. Lackland, Jan N. Basile, et al. American Society of Hypertension Regional Chapters:Leveraging the Impact of the Clinical Hypertension Specialist in the Local Community [J]. AJH,2002,15:372-379. CPAT
[1]邹丽华,黄秀芬,周玉兰,等.高血压患者非药物治疗依从性行为现状调查[J].实用医学杂志,2006,22(21)：2544-2545.
[2]Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy [J]. Am J Hypertens.2006,19(11):1190-6.
[3]Mark A. Munger, Benjamin W. Van Tassell, Joanne LaFleur, et al. Medication Nonadherence:An Unrecognized Cardiovascular Risk Factor [J]. Med Gen Med, 2007,9(3):58.
[4]戴俊明.原发性高血压药物治疗依从性研究[J].中国慢性病预防与控制,2000,8(3)：143-145.
[5]Kyngas H, Duffy M, Kroll T, et al. Conceptual analysis of compliance[J]. Journal of Clinical Nursing,2000,9(1):5-12.
[6]Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken prescribed?[J].JAMA,1989,261(22):3273-3277.
[7]陈首英,尹博英,李贞洁,等.影响高血压患者服药依从性因素调查[J].高血压杂志,2003,11(5)：486-488.
[8]李小红.社区健康教育对老年高血压病患者干预效果研究[J].齐齐哈尔医学院学报,2008,29(4)：510-511.
[9]陶涧,张文武,王娟,等.影响社区高血压治疗与控制率的因素和药物干预[J].基层医学论坛,2008,12(16)：503-504.
[10]戴俊明,傅华,沈贻谔,等.社区高血压患者个体特征与药物治疗依从性关系研究[J].中国公共卫生,2002,18(1)：15-16.
[11]叶晓青,林芳宇,陈维清,等.高血压病患者药物治疗依从性影响因素的研究[J].现代预防医学,2007,34(3)：494-496.
[12]Gray TA, Orton LC, Henson D, et al.Interventions for improving adherence to ocular hypotensive therapy[J]. Cochrane Database Syst Rev,2009,15 (2): 132-133.
[13]Louis-Simonet M, Kossovsky MP, Sarasin FP, et al. Effects of a structured patient-centered discharge interview on patients knowledge about their medications [J]. Aill J Med,2004,117(8):563-568.
[14]邱民.N.A.H小剂量联用治疗高血压依从性观察[J].中国医药杂志,2004,1(3)：131-133.
[15]马菁.高血压患者药物治疗依从性及其影响因素调查[J].中国误诊学杂志,2005,5(9)：1782-1783.
[16]朱秀莲.老年高血压患者用药的依从性及护理对策[J].国际医药卫生导报,2006,12(10)：134-135.
[17]马桂芬,罗薇,张华平,等.对高血压病实施社区护理干预效果分析[J].现代中西医结合杂志,2003,12(4)：421-422.
[18]Roumie CL, Elasy TA. Greevy RImproving blood pressure control through provider education, provider alerts, and patient education:a cluster randomized trial[J], Ann Intern Med,2006,145(3):165-75.
[19]王玉梅,马春蓉,吴莹,等.健康教育对提高原发性高血压患者服药依从性的研究[J].护理研究,2005,19(5)：1893-1894.
[20]杨桂芝.社区高血压患者服药不良行为的护理干预[J].护理学报,2008,15(8)：79-80.
[21]Erdine S. Compliance with the treatment of hypertension:the potential of combination therapy [J]. J Clin Hypertens (Greenwich),2010,12(l):40-6.
[22]Krousel-Wood M, Hyre A, Muntner P, et al. Methods to improve medication adherence in patients with hypertension:Current status and future directions [J]. Curt Opin Cardiol,2005,20(4):296-300.
[23]王桂贤,王桂杰,金淑兰,等.循证护理在老年原发性高血压患者中的应用[J].护理研究,2004,18(10B)：1757-1758.
[24]Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence [J]. J Clin Hypertens (Greenwich), 2006,8:174-180.
[25]崔焱,林征,许勤,等.循证护理教育的实践与探索[J].中国实用护理杂志,2004,20(9)：5.
[26]刘庆伟,姚海云.高血压病患者心态及心理护理后依从性改变的分析[J].山东医药,2005,45(16)：70-72.
[27]Dusing R. Overcoming barriers to effective blood pressure control in patients with hypertension [J].Curr Med Res Opin,2006,22(8):1545-53.
[28]朱英.对社区高血压患者治疗依从性干预作用探讨[J].临床和实验医学杂志,2006,5(12)：2042-2043.
[2]Guzik HJ, Ooi WL. Hypertension:cardiovascular implications in a cohort of old old [J]. J Am Geriatr Soc.1992,40(4):348-53.
[3]全国血压抽样调查协作组,中国高血压的患病率、知晓率及治疗和控制状况：1991年抽样调查结果.高血压杂志.1995,3：14-19.
[4]李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查[J].中华流行病学.2005,26：481-482.
[5]顾东风,JiangHe,吴锡桂,等.中国成年人高血压患病率、知晓率、治疗和控制状况[J].中华预防医学杂志,2003,37(2)：84-85.
[6]徐定修,杨鹏麟.温州市区老年高血压患病率,治疗率及控制情况的调查[J].实用老年医学,1999,13(2)：94-95.
[7]陈春明,孔灵芝.中国成人超重与肥胖症预防控制指南[M].北京：人民卫生出版社,2006：3.
[8]《中国高血压防治指南》2007.
[9]中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值：适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(01)：5-10.
[10]郭子宏,刘锦桃,胡世云,等.云南省长寿地区老年人血压水平调查[J].中华老年医学杂志,2004,23(6)：422-425.
[11]全国血压抽样调查协作组.中国人群体重指数及其与血压关系现况抽样调查研究[J].高血压杂志,1995,3(51)：31-35.
[12]李欣,李绥晶,金旭伟,等.辽宁地区居民体重指数、腰围与血压关系的研究[J].中国预防医学杂志,2007,8(3)：161-163.
[13]王薇,赵冬,刘静,等.中国35-64岁人群血压水平与10年心血管病发病危险的前瞻性究[J].中华内科杂志,2004,43(10)：730-734.
[14]Liu LS, Wang JG, Gong LS, et al. Comparison of active treatment and placebo for older Patients with isolated systolic hypertension [J]. Hypertens.1998,16: 1823-1829.
[15]Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduetion on blood Pressure:a meta-analysis of randomized controlled trials [J]. HyPertension,2003, 42(5):878-884.
[16]JuliusS, Valentini M, Palatini P, et al. Overweight and HyPertension a 2-way street? [J]. HyPertension,2000,35(3):807-813.
[17]赵连成,周北凡,武阳丰,等.体重指数与死亡的前瞻性研究[J].中华流行病学志,2002,23(1)：24-27.
[18]de Jong PE, Vethave JC, Pinto-Sietsma SJ, et al. Obesity and target organ damage:the kidney [J].2002,26(54):21-24.
[19]Hurbert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease:a 26 year follow-up of Participants in Framingham Heart Study [J]. Circulation,1983,67(5):968-977.
[20]方向华,汤哲,平光字,等.北京社区老年人群高血压防治现况的综合评价[J].中华老年医学杂志,2004,23：659-662.
[21]Patricia M Kearney, Megan Whelton, Kristi Reynolds, et al. global burden Of hypertension:analysis of worldwide data [J]. Lancet 2005,365(9455):217-223.
[22]段秀芳,吴锡桂,顾东风,等.中国人群血压分类与高血压患病率研究-1991年血压抽样调查资料的进一步分析[J].高血压杂志,2002,10(3)：271-273.
[23]崔军,张涛,张莉娜,等.宁波市35-74岁城市居民高血压患病情况调查分析[J].疾病监测,2005,20(1)：40-43.
[24]李剑森,马文军,许燕君,等.广东省居民单纯收缩期高血压流行病学特征分析[J].华南预防医学,2003,29(6)：34-36.
[25]Primatesta P, Poulter NR. Hypertension management and control among English adults aged 65 years and older in 2000 and 2001 [J]. J Hypertens,2004,22: 1093-1098.
[26]Franklin SS, JacobsMJ, WongND, et al. Predominance of isolated systolic hypertensives. Analysis based on National Health and Nutrition Examination Survey(NHANES)Ⅲ[J]. Hypertension,2001,37:869-874.
[27]O.James Ekundayo, Richard M.Allman, Paul W.Sanders, et al. Isolated Systolic HyPertension and Incident Heart Failure in older Adults:A ProPensity-Matched Study [J]. HyPertension,2009,53(3):458-465.
[28]Kannel WB. Elevated systolic blood Pressure as a cardiovascular risk factor[J]. Am J Cardio,2000,85(2):251-255.
[29]商青,路方红,孟庆杰,等.山东章丘农民高血压患病率及其危险因素调查[J].中国慢性病预防与控制,2005,13(1)：31-32.
[30]Oliveria SA, Lauerta P, McCarthy BD, et al. physician-related barriers to the effective management of uncontrolled hypertension [J]. Arch Intern Med,2002, 162(4):413-420.
[31]陶寿淇,吴锡桂,周北凡,等.中国人群心血管危险因素作用特点的前瞻性研究[J].中华流行病学杂志,2005,26(1)：58-61.
[32]Stevens VJ, Corigan SA, Obarzanek E, et al. Weight loss intervention in phase I of the Trials of Hypertension Prevention.The TOHP Collaborative Researeh Group. Arch lntem Med.1993,153(7):849-858.
[33]Mulrow CD, Chiquette E, Angel L, et al. WITHDRAWN:Dieting to reduce body weight for controlling hypertension in adults [J]. Cochrane Database Syst Rev. 2008,8 (4):484.
[34]焦淑芳.北京市居民高血压患病及流行趋势分析[J].中国公共卫生,2005,21(12)：1491-1492.
[35]王丽娜,曹丽,张敬一,等.河北省成年居民高血压患病状况及相关因素分析[J].中国慢性病预防与控制,2008,16(2)：125-129.
[36]朱永锋,张娟,邓军,等.县级城乡高血压病防治的流行病学研究[J].大连医科大学学报,2008,30(1)：36-37.
[37]毛浩丹,吴建方,周义红,等.常州市农村地区人群高血压流行病学调查[J].疾病控制杂志,2005,9(5)：406-408.
[38]刘伟佳,陈维清,罗不凡,等.广州市15岁及以上居民高血压流行特征及患病现状[J].中国慢性病预防与控制,2007,15(2)：110-112.
[39]陈捷,赵秀丽,武峰,等.我国14省市中老年人肥胖超重流行现状及其与高血压患病率的关系[J].中华医学杂志,2005,85(40)：2830-2834.
[40]赵连成,武阳丰,周北凡,等.不同体重指数和腰围人群的高血压均值及高血压患病率调查[J].中华流行病学杂志,2003,24(6)：471-475.
[41]傅世英,曹雅,李耀平,等.黑龙江省高血压病流行病学的研究[J].ChioMed J,2002,115(4):498-501.
[42]马文军,林锦炎,陈泽池,等.广东省居民膳食营养与健康状况研究[M].广东人民出版社,2004.
[43]刘蓬勃,王学良,徐慧文,等.原发性高血压遗传流行病学研究.西安医科大 学学报,1996,17(1)：102.
[44]刘蓬勃,王学良,徐慧文,等.遗传因素与原发性高血压.中国公共卫生学报,1995,14(6)：352.
[45]Scott M, Bryan B, Janres I, et al. Definition of metabolic syndrome:Report of The National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues related to Definition. Circulation,2004,109(3): 433-438.
[46]Wilkinson IB, Prasad K, Hall IR, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol, 2002,39(6):1005-1011.
[47]Morisawa T, Kitano M. Influence of angiotensin II type 1 receptor Polymorphism on hyPertension in Patients with hypercholesterolemia. Clin Chim Acta,2001, 304:91.
[48]Ferrier KE, Muhlmarm MH, Baguet JP, et al. Intensive cholesterol reduction lowers blood pressure and large artery stifness in isolated systolic hypertension[J]. J Am Coll Cardiol,2002,39(6):1020-1025.
[49]Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States,1988-2000. JAMA,2003,290:199-206.
[50]Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment and control of hypertension among United States adults 1999-2004. Hypertension, 2007,49:69-75.
[51]张普洪,焦淑芳,周滢,等.北京市2005年18岁及以上居民主要慢性病的流行特征和防治水平调查[J].中华流行病学杂志,2007,28(7)：625-628.
[52]张心刚,孙兆青,叶爱群,等.辽宁省阜新农村地区高血压人群代谢异常研究[J].中华心血管病杂志,2007,35(7)：658-660.
[53]陈秋雯,周建新,赵炜磊,等.上海城乡结合部60岁以上居民的高血压血脂异常高血糖现况调查(附11220例报告)[J].临床心血管病杂志,2009,25(2)：125-128.
[54]Loyd-Jones DM, Evans JC, Larson MG, et al. Cross-classification of JNC VI blood pressure stages and risk group in the Framingham Heart study[J]. Arch Intern Med,1999,159(18):2206-2212.
[55]Wong ND, Pio JR, Franklin SS, et al. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome [J]. Am J cardiol,2003,91(12):1421-1426.
[56]方顺源,施世锋,刘庆敏,等.杭州市城乡居民超重及肥胖与相关疾病关系[J].中国公共卫生,2006,22(7)：852-855.
[57]张龙江.肥胖与胰岛素抵抗[J].实用儿科临床杂志,2009,24(20)：1548-1551.
[58]祁双宝,成守金,许风清,等.中老年高级知识分子1060人体脂分布类型与心血管病危险因素水平及聚集程度的关系[J].中国临床康复,2006,10(36)：7-10.
[59]Coambs R.B, Jensen P, Her MH, et al. Review of the scientific literature on the prevalence consequences and health costs of noncompliance & inappropriate use on prescription medication in Canada [M]. Health promotion research, university of Toronto Press,1995,100.
[60]Cuspidi C, Meani S, Lonati L, et al. Prevalence of home blood pressure measurement among selected hypertensive patients:results of a multicenter survey from six hospital outpatient hypertension clinics in Italy[J]. Blood Press, 2005,14(4):251-256.
[61]范维虎,谢绿洲,董乃琳,等.上海区居民高血压药物治疗概况的横断面调查[J].中国慢性病预防与控制,1994,2(5)：201-202.
[62]Aram V. Chobanian, George L. Bakris, Henry R. Black, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure[J]. Hypertension,2003,42:1206-1252.
[63]李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查[J].中华流行病学,2005,26：481-482.
[64]Eugenia Ch. Yiannakopoulou, John S. Papadopulos, Dennis V. Cokkinos, et al. Adherence to antihypertensive treatment:a critical factor for blood pressure control [J]. European Journal of Cardiovascular Prevention and Rehabilitation, 2005,12:243-249.
[65]Mark A. Munger, Benjamin W. Van Tassell, Joanne LaFleur, et al. Medication Nonadherence:An Unrecognized Cardiovascular Risk Factor[J]. MedGenMed,2007,9(3):58.
[66]陈首英,尹博英,李贞洁,等.影响高血压患者服药依从性因素调查[J].高血压杂志,2003,11(5)：486-488.
[67]于黎,朱大乔.原发性高血压患者药物治疗依从性影响因素的分析[J].解放军护理杂志,2004,21(12)：33-35.
[68]George J. Fodor, Marian Kotrec, Kinga Bacskai, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study [J]. Journal of Hypertension,2005,23:1261-1266.
[69]朱大乔,毛红娟,何丹丹,等.高血压患者自我监测血压对药物治疗依从性的影响[J].中华护理杂志,2004,39(8)：581-583.
[70]姚远,袁洪.降压达标的意义[J].医学综述,2007,13(11)：870.
[71]范维琥,蔡逎绳.高血压[M].见：陈灏珠.实用内科学12版.北京：人民卫生出版社,2005：1525-1544.
[72]张利.1406例高血压合并症分析及社区综合防治的意义[J].中国初级卫生保健,2005,19(8)：51-52.
[73]Xiang Gu, Chunzhi Shi, Yibai Feng, et al. Health education improves effectively therapy of inpatients with Hypertension [J]. Journal of Nanjing Medical University.2006,20(3):129-132.
[74]Richard S Cooper.Using public health indicators to measure the success of hypertension control [J]. Hypertension,2007,49:773-774.
[75]Stergiou GS, Kalogeropoulos PG, Baibas NM, et al. Prognostic value of home blood pressure measurement [J]. Blood Pressure Monitoring,2007,12 (6):391-392.
[76]谢伟林.影响高血压病老年患者治疗依从性的相关因素分析及对策[J].河北医学,2004,10(4)：353-355.
[77]刘建一,李杏桃,张鸿修,等.阶梯剂量联合用药适宜技术在人群高血压病防治中的应用[J].河北医药,2008,30(2)：238-239.
[78]刘建一.NAH治疗方案及微机软件系统在人群高血压病防治中的应用[J].中国慢性病预防与控制,1994,2(6)：272-273.
[79]Ira B.Wilson, Cathy Schoen, Patricia Neuman, et al. Physician-patient communication about prescription medication nonadherence:a 50-state study of America's seniors [J]. J Gen Intern Med,2007,22(1):6-12.
[80]Antoinette Schoenthaler, William F.Chaplin, John P. Allegrante, et al. Provider communication effects medication adherence in hypertensive African Americans[J]. Patient Education and Counseling,2009,75:185-191.
[81]Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence [J]. J Clin Hypertens (Greenwich), 2006,8:174-180.
[82]George S. Stergiou, Petros G. Prognostic value of home blood pressure measurement [J]. Blood Pressure Monitoring,2007,12(6):391-392.
[83]Margaret Scisney-Matlocka, Amy Grandb, Susan P. Steigerwalt, et al. Reliability and reproducibility of clinic and home blood pressure measurements in hypertensive women according to age and ethnicity[J]. Blood Pressure Monitoring,2009,14 (2):49-56.
[84]Brent M. Egan, Daniel T. Lackland, Jan N. Basile, et al. American Society of Hypertension Regional Chapters:Leveraging the Impact of the Clinical Hypertension Specialist in the Local Community [J]. AJH,2002,15:372-379. CPAT
[1]邹丽华,黄秀芬,周玉兰,等.高血压患者非药物治疗依从性行为现状调查[J].实用医学杂志,2006,22(21)：2544-2545.
[2]Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy [J]. Am J Hypertens.2006,19(11):1190-6.
[3]Mark A. Munger, Benjamin W. Van Tassell, Joanne LaFleur, et al. Medication Nonadherence:An Unrecognized Cardiovascular Risk Factor [J]. Med Gen Med, 2007,9(3):58.
[4]戴俊明.原发性高血压药物治疗依从性研究[J].中国慢性病预防与控制,2000,8(3)：143-145.
[5]Kyngas H, Duffy M, Kroll T, et al. Conceptual analysis of compliance[J]. Journal of Clinical Nursing,2000,9(1):5-12.
[6]Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken prescribed?[J].JAMA,1989,261(22):3273-3277.
[7]陈首英,尹博英,李贞洁,等.影响高血压患者服药依从性因素调查[J].高血压杂志,2003,11(5)：486-488.
[8]李小红.社区健康教育对老年高血压病患者干预效果研究[J].齐齐哈尔医学院学报,2008,29(4)：510-511.
[9]陶涧,张文武,王娟,等.影响社区高血压治疗与控制率的因素和药物干预[J].基层医学论坛,2008,12(16)：503-504.
[10]戴俊明,傅华,沈贻谔,等.社区高血压患者个体特征与药物治疗依从性关系研究[J].中国公共卫生,2002,18(1)：15-16.
[11]叶晓青,林芳宇,陈维清,等.高血压病患者药物治疗依从性影响因素的研究[J].现代预防医学,2007,34(3)：494-496.
[12]Gray TA, Orton LC, Henson D, et al.Interventions for improving adherence to ocular hypotensive therapy[J]. Cochrane Database Syst Rev,2009,15 (2): 132-133.
[13]Louis-Simonet M, Kossovsky MP, Sarasin FP, et al. Effects of a structured patient-centered discharge interview on patients knowledge about their medications [J]. Aill J Med,2004,117(8):563-568.
[14]邱民.N.A.H小剂量联用治疗高血压依从性观察[J].中国医药杂志,2004,1(3)：131-133.
[15]马菁.高血压患者药物治疗依从性及其影响因素调查[J].中国误诊学杂志,2005,5(9)：1782-1783.
[16]朱秀莲.老年高血压患者用药的依从性及护理对策[J].国际医药卫生导报,2006,12(10)：134-135.
[17]马桂芬,罗薇,张华平,等.对高血压病实施社区护理干预效果分析[J].现代中西医结合杂志,2003,12(4)：421-422.
[18]Roumie CL, Elasy TA. Greevy RImproving blood pressure control through provider education, provider alerts, and patient education:a cluster randomized trial[J], Ann Intern Med,2006,145(3):165-75.
[19]王玉梅,马春蓉,吴莹,等.健康教育对提高原发性高血压患者服药依从性的研究[J].护理研究,2005,19(5)：1893-1894.
[20]杨桂芝.社区高血压患者服药不良行为的护理干预[J].护理学报,2008,15(8)：79-80.
[21]Erdine S. Compliance with the treatment of hypertension:the potential of combination therapy [J]. J Clin Hypertens (Greenwich),2010,12(l):40-6.
[22]Krousel-Wood M, Hyre A, Muntner P, et al. Methods to improve medication adherence in patients with hypertension:Current status and future directions [J]. Curt Opin Cardiol,2005,20(4):296-300.
[23]王桂贤,王桂杰,金淑兰,等.循证护理在老年原发性高血压患者中的应用[J].护理研究,2004,18(10B)：1757-1758.
[24]Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence [J]. J Clin Hypertens (Greenwich), 2006,8:174-180.
[25]崔焱,林征,许勤,等.循证护理教育的实践与探索[J].中国实用护理杂志,2004,20(9)：5.
[26]刘庆伟,姚海云.高血压病患者心态及心理护理后依从性改变的分析[J].山东医药,2005,45(16)：70-72.
[27]Dusing R. Overcoming barriers to effective blood pressure control in patients with hypertension [J].Curr Med Res Opin,2006,22(8):1545-53.
[28]朱英.对社区高血压患者治疗依从性干预作用探讨[J].临床和实验医学杂志,2006,5(12)：2042-2043.